Table 1.

Percent blood glucose reduction produced by T.chebula after oral administration in streptozotocin-induced diabetic rats.

Group (n = 5)	Dose (mg/kg)	Percent blood glucose reduction
		0.5	1	2	4	6	8	12 (hrs)
Control	---	-5.65 ± 1.80	-8.10 ± 3.29	-1.35 ± 6.62	-12.09 ± 4.48	-7.25 ± 4.90	-4.19 ± 2.08	-7.03 ± 8.15
T.chebula	100	-2.18 ± 3.95	8.45 ± 9.27	17.82 ± 5.38*	20.85 ± 5.29*	19.94 ± 6.18*	10.98 ± 8.54	8.36 ± 3.18
T.chebula	200	1.28 ± 4.72	20.28 ± 6.29*	31.98 ± 8.24**	28.45 ± 6.20**	26.55 ± 2.70**	18.25 ± 5.21*	12.86 ± 8.20*
T.chebula	300	-1.18 ± 4.25	25.88 ± 10.05**	38.92 ± 7.18**	42.20 ± 4.65**	33.09 ± 8.05**	27.85 ± 4.78**	22.90 ± 7.55**
Glibenclamide	0.04	24.92 ± 8.20*	32.37 ± 4.60**	38.72 ± 10.22**	50.44 ± 8.40**	46.56 ± 4.60**	23.11 ± 6.75*	10.26 ± 11.03

Values are represented as mean ± SEM.; n = number of animals per group

Significant difference from control group at identical times, *P < 0.01; **P < 0.001